Hims & Hers Health Analyst Rating Update On July 23, 2026, Citigroup maintained a Neutral rating on…
Why is Hims & Hers Health stock rallying today?…
Explore Hims & Hers Health, Inc. stock analysis amid FDA catalyst and neutral technical signals. Understand the key price levels…
On July 23, 2026, Hims & Hers Health Inc (HIMS) saw its stock price increase by more than 10% after…
Hims & Hers Health (HIMS) stock rises as an FDA panel backs placing popular peptide BPC-157 in a list compounding…
On July 23, 2026, shares of Hims & Hers Health Inc (HIMS) experienced a notable increase following a recent decision…
Hims & Hers Health shares jump on FDA’s push to expand BPC-157 access…
Hims & Hers Health ( ($HIMS) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual…
Hims & Hers stock jumps after FDA panel backs BPC-157 access…
Hims & Hers Health is set to tap what analysts estimate could be a multi-billion-dollar market for peptides if U.S.…
By Amina NiasseHims & Hers Health NYSE:HIMS is set to tap what analysts estimate could be a multi-billion-dollar market for…
On July 22, 2026, Hims & Hers Health Inc (HIMS) shares fell 3.2% to $31.68. This decline is part of…
Hims & Hers Health, Inc. (HIMS) closed the most recent trading day at $31.68, moving 3.21% from the previous trading…
Hims & Hers Health, Inc. (HIMS) closed the most recent trading day at $31.68, moving 3.21% from the previous trading…
On July 22, 2026, recent analysis from Morgan Stanley reveals a positive shift for Hims & Hers (HIMS), as app…
$290,000 of HIMS & HERS HEALTH INC. lobbying was just disclosed, from Q2 of 2026, in a new Lobbying Disclosure…
Hims & Hers Health short interest was 31.82% of the float on June 30th, according to new data we received…
Hims & Hers stock analysis: growth story meets credibility crisis ahead of FDA catalyst…
Hims & Hers Health trades at $32.7 today, down 0.43%. Technicals show weak momentum and sideways price expected short term.…
Hims & Hers Health Inc. (NYSE: HIMS) announced that Chief Accounting Officer Irene Becklund will leave the company on Oct....…
Price-action only: Hims & Hers Health Inc. Class A (HIMS) movements set the tone for institutional models. Technical Reactions to…
On July 18, 2026, Hims & Hers Health Inc (HIMS) announced the upcoming departure of Chief Accounting Officer Irene Becklund,…
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced its Chief Accounting…
On July 17, 2026, Hims & Hers Health Inc (NYSE: HIMS) announced that its Chief Accounting Officer, Irene Becklund, will…
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced its Chief Accounting…
Hims & Hers chief accounting officer to depart in October…
Hims & Hers chief accounting officer to depart in October…
SAN FRANCISCO--(BUSINESS WIRE)--Jul 17, 2026--…
Executive change sees CAO Irene Becklund leaving Hims & Hers Health in October 2026 while remaining under an advisory agreement…
Hims & Hers Health trades at $33.39 per share and has stayed right on track with the overall market, gaining…
Hims & Hers Health (HIMS) is down 3.5% today. Here is some analysis on what might have caused this price…